Science Explorer Back to mapMap
Discussion
Researcher · Advanced Bioscience Laboratories (United States) · United States

Vaniambadi S. Kalyanaraman

Vaniambadi S. Kalyanaraman publishes mostly in Immunology, Virology and Infectious Diseases, on topics such as HIV Research and Treatment, Immune Cell Function and Interaction and HIV/AIDS drug development and treatment.

OpenAlex
World rank
#2,677,525
of 7,710,434 ranked researchers
Rank in United States
#782,050
of 1,627,098
Works
78
Citations
3.3k
Citations per work
42.0
h-index
34
i10-index 60Top 11% in Immunology
Vaniambadi S. Kalyanaraman

What does Vaniambadi S. Kalyanaraman research?

Vaniambadi S. Kalyanaraman's work is mostly in Immunology and Microbiology (59%), Medicine (22%), Biochemistry, Genetics and Molecular Biology (7%).

Life Sciences: 52 works · 66.2% of their workImmunology and Microbiology: 46 works · 58.8% of their workImmunology: 23 works · 29.4% of their workVirology: 23 works · 29.4% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 7.4% of their workMolecular Biology: 3 works · 3.9% of their workGenetics: 3 works · 3.5% of their workHealth Sciences: 17 works · 21.5% of their workMedicine: 17 works · 21.5% of their workInfectious Diseases: 10 works · 12.7% of their workEpidemiology: 7 works · 8.8% of their workEverything else: 10 works · 12.3% of their workTHEIR WORKVaniambadi S.Kalyanaraman78works
Life Sciences66%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology4658.8%
    2. Biochemistry, Genetics and Molecular Biology67.4%
    1. Medicine1721.5%
  3. Everything else1012.3%
  1. 1Immunology29% of their works
  2. 2Virology29% of their works
  3. 3Infectious Diseases13% of their works
  4. 4Epidemiology9% of their works
  5. 5Molecular Biology4% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Vaniambadi S. Kalyanaraman's research?

The keywords of their largest research topics: Antiretroviral Therapy, Immune Response, Vaccine, AIDS, HIV, Natural Killer Cells, NK Cell Recognition and Epidemiology.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Antiretroviral Therapy862 topics
  2. Immune Response792 topics
  3. Vaccine792 topics
  4. AIDS661 topic
  5. HIV661 topic
  6. NK Cell Recognition301 topic
  7. Natural Killer Cells301 topic
  8. Epidemiology212 topics
  9. Drug Resistance201 topic
  10. HIV Infection201 topic
  11. Herpes Zoster131 topic
  12. Herpesviruses131 topic
  13. Dendritic Cells111 topic
  14. Immunity111 topic
  15. Foxp381 topic
  16. Gene Therapy81 topic
  17. HTLV-181 topic
  18. Infection81 topic
  19. TGF-ß81 topic
  20. Viral Vectors81 topic

Where does Vaniambadi S. Kalyanaraman work?

Vaniambadi S. Kalyanaraman's main affiliation in the publication record is Advanced Bioscience Laboratories (United States), United States.

How many publications and citations does Vaniambadi S. Kalyanaraman have?

OpenAlex counts 78 works and 3,278 citations for Vaniambadi S. Kalyanaraman, an h-index of 34, ranking #2,677,525 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Vaniambadi S. Kalyanaraman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.